2021 Q2 Form 10-Q Financial Statement

#000120179221000009 Filed on August 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $78.01M $82.13M
YoY Change -5.01% 16.39%
Cost Of Revenue $30.39M $30.74M
YoY Change -1.14% 7.03%
Gross Profit $47.62M $51.38M
YoY Change -7.32% 22.82%
Gross Profit Margin 61.04% 62.57%
Selling, General & Admin $42.95M $38.79M
YoY Change 10.71% 20.44%
% of Gross Profit 90.19% 75.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.525M $3.390M
YoY Change -25.52% -13.96%
% of Gross Profit 5.3% 6.6%
Operating Expenses $42.95M $38.79M
YoY Change 10.71% 20.44%
Operating Profit $1.975M $9.041M
YoY Change -78.16% 59.23%
Interest Expense $24.00K $179.0K
YoY Change -86.59% -84.23%
% of Operating Profit 1.22% 1.98%
Other Income/Expense, Net
YoY Change
Pretax Income $1.999M $9.220M
YoY Change -78.32% 35.33%
Income Tax $646.0K $2.532M
% Of Pretax Income 32.32% 27.46%
Net Earnings $531.0K $6.689M
YoY Change -92.06% 35.93%
Net Earnings / Revenue 0.68% 8.14%
Basic Earnings Per Share $0.03 $0.45
Diluted Earnings Per Share $0.03 $0.45
COMMON SHARES
Basic Shares Outstanding 18.68M shares 14.79M shares
Diluted Shares Outstanding 18.84M shares 14.95M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $317.0M $216.0M
YoY Change 46.74% -2.17%
Cash & Equivalents $317.0M $216.0M
Short-Term Investments
Other Short-Term Assets $9.466M $9.400M
YoY Change 0.7% 18.99%
Inventory
Prepaid Expenses $9.466M $9.426M
Receivables $18.95M $6.922M
Other Receivables $5.099M $2.600M
Total Short-Term Assets $350.5M $235.0M
YoY Change 49.14% -2.07%
LONG-TERM ASSETS
Property, Plant & Equipment $65.82M $74.08M
YoY Change -11.14% -9.29%
Goodwill $26.56M $26.56M
YoY Change 0.0% -5.28%
Intangibles
YoY Change
Long-Term Investments $9.668M $10.50M
YoY Change -7.92% 101.92%
Other Assets $7.220M $5.087M
YoY Change 41.93% -1.36%
Total Long-Term Assets $118.4M $126.7M
YoY Change -6.52% -6.92%
TOTAL ASSETS
Total Short-Term Assets $350.5M $235.0M
Total Long-Term Assets $118.4M $126.7M
Total Assets $468.9M $361.7M
YoY Change 29.64% -3.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.047M $5.034M
YoY Change -39.47% 2.25%
Accrued Expenses $10.95M $8.551M
YoY Change 28.07% 26.44%
Deferred Revenue $21.60M $20.80M
YoY Change 3.85% 9.16%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $54.33M $53.85M
YoY Change 0.89% 27.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.233M $8.300M
YoY Change -12.86% -9.78%
Total Long-Term Liabilities $7.233M $8.300M
YoY Change -12.86% -9.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.33M $53.85M
Total Long-Term Liabilities $7.233M $8.300M
Total Liabilities $65.79M $68.09M
YoY Change -3.38% 18.15%
SHAREHOLDERS EQUITY
Retained Earnings $119.8M $101.5M
YoY Change 18.09% -22.14%
Common Stock $283.3M $192.1M
YoY Change 47.45% 2.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $403.1M $293.6M
YoY Change
Total Liabilities & Shareholders Equity $468.9M $361.7M
YoY Change 29.64% -3.82%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $531.0K $6.689M
YoY Change -92.06% 35.93%
Depreciation, Depletion And Amortization $2.525M $3.390M
YoY Change -25.52% -13.96%
Cash From Operating Activities -$2.332M $20.23M
YoY Change -111.53% 27.88%
INVESTING ACTIVITIES
Capital Expenditures $1.500M $1.024M
YoY Change 46.48% -25.36%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.498M -$1.020M
YoY Change 46.86% -25.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -33.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.332M 20.23M
Cash From Investing Activities -1.498M -1.020M
Cash From Financing Activities -33.00K 0.000
Net Change In Cash -3.863M 19.21M
YoY Change -120.11% 292.04%
FREE CASH FLOW
Cash From Operating Activities -$2.332M $20.23M
Capital Expenditures $1.500M $1.024M
Free Cash Flow -$3.832M $19.21M
YoY Change -119.95% 32.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001201792
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33810
dei Entity Registrant Name
EntityRegistrantName
AMERICAN PUBLIC EDUCATION, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
01-0724376
dei Entity Address Address Line1
EntityAddressAddressLine1
111 West Congress Street,
dei Entity Address City Or Town
EntityAddressCityOrTown
Charles Town,
dei Entity Address State Or Province
EntityAddressStateOrProvince
WV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
25414
dei City Area Code
CityAreaCode
304
dei Local Phone Number
LocalPhoneNumber
724-3700
dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
dei Trading Symbol
TradingSymbol
APEI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18694299 shares
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
316953000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227686000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7204000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5983000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18949000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17652000 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9466000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6472000 USD
CY2021Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5099000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
350467000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
251810000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65823000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
68434000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9175000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8743000 USD
CY2021Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
9668000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
10495000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
26563000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
26563000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7220000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4973000 USD
CY2021Q2 us-gaap Assets
Assets
468916000 USD
CY2020Q4 us-gaap Assets
Assets
371018000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3047000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3757000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16564000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15660000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10951000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10967000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21625000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
22104000 USD
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
178000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2143000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2392000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
54330000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
55058000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7233000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6455000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4228000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2580000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
65791000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
64093000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18689000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18689000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14809000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14809000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
187000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
148000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
283120000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
195597000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
119818000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
111180000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
403125000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
306925000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
468916000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
371018000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78014000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
82127000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166555000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156743000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30394000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30744000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62713000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
59974000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17490000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17056000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36892000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
35242000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25457000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21737000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48981000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42740000 USD
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-174000 USD
CY2020Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-158000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-182000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-324000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2524000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3391000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5175000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6729000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
76039000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
73086000 USD
us-gaap Costs And Expenses
CostsAndExpenses
153943000 USD
us-gaap Costs And Expenses
CostsAndExpenses
145009000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1975000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9041000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
12612000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
11734000 USD
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
24000 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
179000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
138000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
881000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1999000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9220000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12750000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12615000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
646000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2532000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3285000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3506000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-822000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-827000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
531000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
6689000 USD
us-gaap Net Income Loss
NetIncomeLoss
8638000 USD
us-gaap Net Income Loss
NetIncomeLoss
9109000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18684000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14789000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17454000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14907000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18840000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14948000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17654000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15026000 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
296733000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1946000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3323000 USD
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
13608000 USD
us-gaap Net Income Loss
NetIncomeLoss
9109000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
293611000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
306925000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3680000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
86209000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2812000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4165000 USD
us-gaap Net Income Loss
NetIncomeLoss
8638000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
403125000 USD
us-gaap Net Income Loss
NetIncomeLoss
8638000 USD
us-gaap Net Income Loss
NetIncomeLoss
9109000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5175000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6729000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4165000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3323000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-827000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1648000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
2570000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-182000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-324000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-10000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1297000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4403000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3133000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2727000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-5277000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-844000 USD
apei Increase Decrease In Operating Leases Net
IncreaseDecreaseInOperatingLeasesNet
-97000 USD
apei Increase Decrease In Operating Leases Net
IncreaseDecreaseInOperatingLeasesNet
-53000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
875000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
317000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-413000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1202000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
904000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3352000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1267000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1201000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-479000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3357000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8898000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31745000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3028000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2893000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3028000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2893000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2812000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15554000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
86209000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
83397000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15554000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
89267000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13298000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227686000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202740000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
316953000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
216038000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
6887000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1780000 USD
us-gaap Nature Of Operations
NatureOfOperations
Nature of the Business<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Public Education, Inc., or APEI, which together with its subsidiaries is referred to as the “Company,” is a provider of online and campus-based postsecondary education to approximately 91,500 students through two subsidiary institutions:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">American Public University System, Inc., or APUS, provides online postsecondary education directed primarily at the needs of the military, military-affiliated, public service and service-minded communities through American Military University, or AMU, and American Public University, or APU. APUS is institutionally accredited by the Higher Learning Commission, or HLC.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">National Education Seminars, Inc., which is referred to herein as Hondros College of Nursing, or HCN, provides nursing education to students enrolled at six campuses in Ohio, including a campus in Akron that opened in April 2021, and a campus in Indianapolis, Indiana, to serve the needs of the nursing and healthcare communities. HCN is institutionally accredited by the Accrediting Bureau for Health Education Schools, or ABHES. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s institutions are licensed or otherwise authorized, or are in the process of obtaining such licenses or authorizations, to offer postsecondary education programs by state authorities to the extent the institutions believe such licenses or authorizations are required, and are certified by the United States Department of Education, or ED, to participate in student financial aid programs authorized under Title IV of the Higher Education Act of 1965, as amended, or Title IV programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    The Company’s operations are organized into two reportable segments:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">American Public Education Segment, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> APEI Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This segment reflects the operational activities at APUS, other corporate activities, and minority investments.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hondros College of Nursing Segment, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> HCN Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This segment reflects the operational activities of HCN.</span></div>
apei Number Of Students
NumberOfStudents
91500 student
apei Number Of Subsidiaries
NumberOfSubsidiaries
2 subsidiary
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing financial statements in conformity with GAAP, the Company is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. The Company evaluates these estimates and assumptions on an ongoing basis and bases its estimates on experience, current and expected future conditions, and various other assumptions that the Company believes are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions, and the impact of such differences may be material to the Company’s Consolidated Financial Statements.</span></div>
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1000000.0 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1200000 USD
CY2021Q2 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
8500000 USD
CY2020Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2021Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
apei Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Service Period
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedServicePeriod
P1Y
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1985000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1573000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4165000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3323000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78014000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
82127000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166555000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156743000 USD
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21600000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
22100000 USD
us-gaap Variable Lease Payment
VariableLeasePayment
0 USD
CY2021Q2 us-gaap Variable Lease Payment
VariableLeasePayment
0 USD
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1600000 USD
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1500000 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
800000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1500000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
700000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1400000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1148000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2815000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2059000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1282000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
852000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
852000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1778000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10786000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1410000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9376000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2143000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7233000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9376000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M4D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18684000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14789000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17454000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14907000 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
156000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
159000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
200000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
119000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18840000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14948000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17654000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15026000 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
84000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
196000 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78014000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
82127000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166555000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156743000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2524000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3391000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5175000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6729000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1975000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9041000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
12612000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
11734000 USD
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
24000 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
179000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
138000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
881000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
646000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2532000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3285000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3506000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1500000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1024000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3028000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2893000 USD
CY2021Q2 us-gaap Assets
Assets
468916000 USD
CY2020Q4 us-gaap Assets
Assets
371018000 USD

Files In Submission

Name View Source Status
0001201792-21-000009-index-headers.html Edgar Link pending
0001201792-21-000009-index.html Edgar Link pending
0001201792-21-000009.txt Edgar Link pending
0001201792-21-000009-xbrl.zip Edgar Link pending
apei-20210630.htm Edgar Link pending
apei-20210630.xsd Edgar Link pending
apei-20210630_cal.xml Edgar Link unprocessable
apei-20210630_def.xml Edgar Link unprocessable
apei-20210630_g1.jpg Edgar Link pending
apei-20210630_htm.xml Edgar Link completed
apei-20210630_lab.xml Edgar Link unprocessable
apei-20210630_pre.xml Edgar Link unprocessable
exhibit311q221.htm Edgar Link pending
exhibit312q221.htm Edgar Link pending
exhibit321q221.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending